Back to Search
Start Over
[Mixed connective tissue disease and its management].
- Source :
-
Revue medicale suisse [Rev Med Suisse] 2024 Apr 03; Vol. 20 (868), pp. 699-704. - Publication Year :
- 2024
-
Abstract
- Mixed connective tissue disease (MCTD) is a rare autoimmune condition. Since its first description 50 years ago, its mere existence has been debated, given that it shares features of other autoimmune diseases, such as systemic lupus erythematosus (SLE), systemic sclerosis, inflammatory myopathy, rheumatoid arthritis and Sjogren's syndrome. Also, while antibodies to U1-RNP are essential for the diagnosis of MCTD, these antibodies may be expressed in other circumstances, such as in case of SLE. Nevertheless, the patient fulfilling criteria for MCTD needs specific management. In this review, we describe the clinical features and the potential complications of this complex disease, often wrongly disregarded as benign. We will also emphasize the recommended follow-up exams and address treatment, which is currently lacking formal recommendations.<br />Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
- Subjects :
- Humans
Existentialism
Rare Diseases
Mixed Connective Tissue Disease complications
Mixed Connective Tissue Disease diagnosis
Mixed Connective Tissue Disease therapy
Autoimmune Diseases
Arthritis, Rheumatoid
Lupus Erythematosus, Systemic complications
Lupus Erythematosus, Systemic diagnosis
Lupus Erythematosus, Systemic therapy
Subjects
Details
- Language :
- French
- ISSN :
- 1660-9379
- Volume :
- 20
- Issue :
- 868
- Database :
- MEDLINE
- Journal :
- Revue medicale suisse
- Publication Type :
- Academic Journal
- Accession number :
- 38568063
- Full Text :
- https://doi.org/10.53738/REVMED.2024.20.868.699